Whither thromboprophylaxis after total hip replacement?
Thomas
D P
DP
National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK.
D000925:Anticoagulants / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip / Q000639:trends*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication / Q000639:trends; D012307:Risk Factors; D013923:Thromboembolism / Q000097:blood / Q000235:genetics / Q000517:prevention & control*; D015912:Thrombolytic Therapy / Q000639:trends*
D000925:Anticoagulants; D005343:Fibrinolytic Agents